hong-kong-gdp-requirements-2026.png

HK GDP Guide Audit

From Q3 2026, compliance with the Hong Kong GDP Guide becomes a licensing condition for ML and WDL holders. There is no certificate to collect — only an inspection to pass. We help you be ready for it.


Let's be clear about what this is, and what it isn't

Most of what you'll read about "GDP certification" online was written for Europe. Hong Kong works differently, and the difference matters:

In the EU/UK, the regulator conducts inspections and, once compliance is confirmed, issues a GDP certificate. This certificate serves as the company’s proof of compliance with Good Distribution Practice. Since the authority itself certifies, no third-party certification is required.

In Hong Kong, the regulator also inspects companies, but instead of issuing a separate GDP certificate, compliance is confirmed as a licensing condition. The company ultimately holds its ML or WDL licence, with GDP compliance attached as a condition. As in the EU/UK, third-party certification is not required, because the regulator directly confirms compliance.

So we'll say it plainly: there is no statutory GDP certificate in Hong Kong, and no legal requirement to engage a certification body. Any provider telling you otherwise has not read the documents.

 

Then why would you engage us?

Because the GDP Guide itself puts it on the record. It states that WDL holders may consider an external audit, by an auditor experienced in conducting audits to PIC/S or other international standards (such as the World Health Organization), to be conducted once the QMS has been implemented — to ensure that core requirements are covered.

That isn't our sales pitch. That is the regulatory guidance naming the practice.

And it draws the boundary just as clearly: it is not acceptable to replace self-inspections with external audits or regulatory inspections — though a company may take into consideration external audits by external experts when assessing the scope of its self-inspections.

Operating entirely within compliance frameworks, our service does not substitute for your internal self-inspections. Instead, we offer a professional third-party assessment to verify that your self-inspection system aligns with regulatory compliance and audit standards.

What we deliver

  • Gap Analysis against the GDP Guide (HK) Ver 2026

Clause-by-clause assessment against Part I (pharmaceutical products) and, where applicable, Part II (active substances). You receive a prioritised findings register separating three categories that matter:

  1. Compliant
  2. Practised but undocumented — the largest and most under-estimated category. "We've always done it this way" with no record counts as not done.
  3. Absent
  • Independent Readiness Audit

Performed once your QMS is implemented, by auditors experienced in PIC/S and international standards — verifying that core requirements are genuinely covered, not merely written down.

  • GDP Guide (HK) Understanding Course

The course is for RPs, QA, warehouse, and logistics personnel. Covers the GDP Guide itself and the SOPs that operationalise it. It can be delivered in Cantonese, English, or Mandarin as agreed in advance.

  • International GDP Certification

For organisations that also need a management system certification for cross-border supply chain access — see our [GDP Certification]. It is intended for GDP standards of EU, WHO, or USP at present.

Who this is for

  • Licensed wholesale dealers (WDL holders)

Directly regulated. This is a mandatory requirement for maintaining your licence.

  • Licensed manufacturers (ML holders)

You already comply with the Board's GMP Guide — but GDP brings the distribution stage out as an explicit, separate set of requirements. GMP does not cover whether your carrier maintained temperature.

  • Logistics, warehousing and transport providers

You may hold no licence at all — and you are still exposed. WDL holders must control outsourced activities and gather and consider the relevant background information of their contract acceptors. Your customers are going to audit you. A 3PL without demonstrable GDP capability gets designed out of the pharmaceutical supply chain.

  • Medical gas businesses

Medical gases are regulated as pharmaceutical products from 14 June 2026. You are absorbing two regulatory shifts at once.

  • One-person and small operators

The Guide is explicit: a WDL holder which is a one-person company should also develop a quality system. Proportionate in scale — but it must exist.

Why "we have until 2028" is the wrong conclusion

  • Gap analysis: The implementation process usually begins with a gap analysis, taking about one to two months to identify discrepancies between current practices and regulatory requirements.
  • SOPs and system documentation: This is a longer stage, typically lasting four to eight months, during which procedures are written and systems formally documented.
  • Training and personnel qualification: Once the framework is established, focus shifts to training and personnel qualification, generally requiring two to three months to ensure staff are competent and certified.
  • Warehouse temperature mapping: This must cover both summer and winter extremes, spanning twelve months to capture seasonal variations.
  • Transport route qualification: Usually takes three to six months to validate logistics pathways.
  • First self‑inspection and CAPA closure: A two to three‑month process to identify and correct deficiencies.
  • External verification and remediation: Finally, the process concludes with external verification and remediation, requiring an additional two to four months to complete independent audits and address findings.

Temperature mapping is the binding constraint. Demonstrating your warehouse holds temperature at the hottest and coldest points of the year requires a full annual cycle. It cannot be compressed. It cannot be bought faster.

Start in late 2027 and you will not have the seasonal data.

And if you are applying for a new licence, opening a new warehouse, or standing up a new entity — your deadline is 2026, not 2028.

How we work

  1. Scoping conversation — your licence type, product scope (Part I / Part II), sites, and where you are today.
  2. Tailored proposal — priced against objective scope, not a blanket rate card.
  3. Gap analysis — clause-by-clause, with a prioritised remediation roadmap.
  4. Remediation window — your team executes; we stay available for technical questions.
  5.  Readiness audit — independent verification that core requirements are covered.
  6. Training — 1.5-day Understanding Course for the people who have to run this daily.

Why DQS

  • Auditors experienced in international GDP standards — the specific expertise aligned with the GDP Guide requirements.
  • Local presence in Hong Kong, with global pharmaceutical supply chain reach
  • We tell you what the documents actually say — including the parts that mean you need less from us than you expected

Frequently asked questions

  • Will DQS certification satisfy the Pharmacy and Poisons Board?

No — and no third party's will. Compliance is confirmed by the Board through licensing conditions and inspection. Our role is to find the gaps before the inspector does.

  • Can your audit replace our self-inspection?

No. The Guide states plainly that replacing self-inspections with external audits or regulatory inspections is not acceptable. Our findings can inform how you scope your self-inspections.

  • Is the GDP Guide actually law?

Not legislation itself. Its force comes from the Pharmacy and Poisons Ordinance (Cap. 138) and Regulations (Cap. 138A), which require a licence — and the Board attaches GDP compliance as a licensing condition. Technically not law; operationally mandatory.

  • Which standard does Hong Kong use?

PIC/S PE 011-1 (medicinal products → Part I) and PIC/S PI 047-1 (active substances → Part II).

  • We're already EU GDP certified — are we covered in Hong Kong?

Substantially convergent, but not identical documents. Your existing system is a strong head start; it still needs mapping against the HK Guide, and HK's enforcement mechanism differs. We can scope a delta assessment.

  • We only deal in chemical reagents / hair dyes / industrial chemicals.

Trade dealing solely in non-medicinal poisons is out of scope. The word "solely" is doing all the work — any pharmaceutical product in your range removes the exemption.

  • Are the documents final?

No. The consultation closed 31 May 2026; the Board will finalise after considering stakeholder feedback, with promulgation tentatively Q3 2026. Wording may change. We track this and adjust scope accordingly.

 

→ [Read the full breakdown of the Hong Kong GDP requirements]

The inspector will find what you didn't look for

Give us a scope, and we'll tell you honestly how far you are — including if the answer is "closer than you think."

Request a quote